Registered Kenya · PPB

TIMENTIN INJECTION

TICARCILLIN

H90443 3.2G INN generic

What it does

Ticarcillin is an antibiotic that belongs to the penicillin group. It is used to treat various bacterial infections.

Commonly used for: bacterial infections, infections caused by susceptible bacteria

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H90443
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
TICARCILLIN
Dosage form
3.2G
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Glaxosmithkline
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
MVQ4+VWW, Likoni Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:43:21 · updated 2026-07-20 11:17:46

Drug Interactions

6
Check interactions

Severe (1)

Penicillins - increases risk of adverse effects

Valproate increases the risk of adverse effects when given with penicillins (pivmecillinam). Avoid.

Severe Anecdotal

Unknown (5)

Penicillins - increases risk of skin rash

Allopurinol increases the risk of skin rash when given with penicillins (amoxicillin, ampicillin).

Unknown Study

Penicillins - increases exposure

Leflunomide is predicted to increase the exposure to penicillins (benzylpenicillin).

Unknown Theoretical

Penicillins - increases exposure

Nitisinone is predicted to increase the exposure to penicillins (benzylpenicillin).

Unknown Study

Penicillins - increases exposure

Teriflunomide is predicted to increase the exposure to penicillins (benzylpenicillin).

Unknown Study

Phenindione - increases risk of bleeding events

Penicillins are predicted to increase the risk of bleeding events when given with phenindione.

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: class

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Ticarcillin is an antibiotic that belongs to the penicillin group. It is used to treat various bacterial infections.

What it treats

  • bacterial infections
  • infections caused by susceptible bacteria

How it works

Ticarcillin works by killing bacteria or stopping their growth, helping to clear infections from the body.

Who it's for

Ticarcillin is for individuals with certain bacterial infections as determined by a healthcare professional.

Drug class

Penicillins

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: ticarcillin

BNF-referenced

Ticarcillin is a semisynthetic penicillin antibiotic classified under the group of penicillins. It is primarily used to treat infections caused by susceptible bacteria, particularly those that are gram-negative. Ticarcillin is designed to combat various bacterial infections through its bactericidal properties, making it effective for serious infections requiring antibiotic intervention.

Indications

  • Bacterial infections
  • Pneumonia
  • Urinary tract infections
  • Skin and soft tissue infections
  • Intra-abdominal infections
  • Sepsis

Dosage

Children: Refer to the BNF for Children for paediatric dosing recommendations.

Adults: Refer to the BNF for specific dosing guidelines.

Mechanism of action

Ticarcillin's principal mechanism of action revolves around its capacity to prevent the cross-linking of peptidoglycan during bacterial cell wall synthesis. Consequently, when the offending bacteria attempt to undergo cell division, cell death occurs.

Pharmacodynamics

Ticarcillin is a semisynthetic antibiotic with a broad spectrum of bactericidal activity against many gram-positive and gram-negative aerobic and anaerobic bacteria. Ticarcillin is, however, susceptible to degradation by ß-lactamases, and therefore, the spectrum of activity does not normally include organisms which produce these enzymes.

Pharmacokinetics

Ticarcillin is typically administered parenterally and exhibits a rapid distribution in body tissues. It is primarily excreted unchanged in the urine. The pharmacokinetics can be influenced by renal function, necessitating dosage adjustments in patients with impaired kidney function.

Pregnancy

Ticarcillin is classified as a pregnancy category B drug. Animal studies have not demonstrated a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.

Breast-feeding

Ticarcillin is excreted in human milk. Caution should be exercised when administering to nursing mothers, as potential effects on the infant are unknown.

Storage

Store below 25°C. Protect from light. Reconstituted solutions should be used promptly or stored at 2-8°C and used within 24 hours.

Formulations

  • Ticarcillin disodium

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: ticarcillin

PubChem CID 36921

Molecular formula: C15H16N2O6S2

Mechanism of action

Ticarcillin's principal mechanism of action revolves around its capacity to prevent the cross-linking of peptidoglycan during bacterial cell wall synthesis. Consequently, when the offending bacteria attempt to undergo cell division, cell death occurs.

Pharmacodynamics

Ticarcillin is a semisynthetic antibiotic with a broad spectrum of bactericidal activity against many gram-positive and gram-negative aerobic and anaerobic bacteria. Ticarcillin is, however, susceptible to degradation by ß-lactamases, and therefore, the spectrum of activity does not normally include organisms which produce these enzymes.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.